Entero Therapeutics Price Patterns
| ENTODelisted Stock | 2.85 0.15 5.00% |
Momentum 52
Impartial
Oversold | Overbought |
Using Entero Therapeutics hype-based prediction, you can estimate the value of Entero Therapeutics from the perspective of Entero Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Entero Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Entero because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Entero Therapeutics after-hype prediction price | USD 2.86 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Entero |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Entero Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Entero Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Entero Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Entero Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Entero Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Entero Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Entero Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Entero Therapeutics' historical news coverage. Entero Therapeutics' after-hype downside and upside margins for the prediction period are 0.14 and 12.70, respectively. We have considered Entero Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Entero Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Entero Therapeutics is based on 3 months time horizon.
Entero Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Entero Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Entero Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Entero Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.06 | 9.84 | 0.01 | 0.00 | 5 Events / Month | 6 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.85 | 2.86 | 0.35 |
|
Entero Therapeutics Hype Timeline
Entero Therapeutics is currently traded for 2.85. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.0. Entero is anticipated to increase in value after the next headline, with the price projected to jump to 2.86 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.35%, whereas the daily expected return is currently at -0.06%. The volatility of related hype on Entero Therapeutics is about 20081.63%, with the expected price after the next announcement by competition of 2.85. Net Loss for the year was (18.06 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days. Check out Entero Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics guide.Entero Therapeutics Related Hype Analysis
Having access to credible news sources related to Entero Therapeutics' direct competition is more important than ever and may enhance your ability to predict Entero Therapeutics' future price movements. Getting to know how Entero Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Entero Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CRIS | Curis Inc | (0.04) | 7 per month | 0.00 | (0.08) | 10.62 | (8.13) | 33.70 | |
| PCSA | Processa Pharmaceuticals | (0.04) | 9 per month | 0.00 | (0.05) | 11.68 | (14.08) | 164.28 | |
| BCTX | Briacell Therapeutics Corp | (0.28) | 8 per month | 0.00 | (0.07) | 13.96 | (9.09) | 98.43 | |
| PALI | Palisade Bio | 0.14 | 10 per month | 0.00 | (0.05) | 13.66 | (10.26) | 31.35 | |
| CTXR | Citius Pharmaceuticals | 0.1 | 9 per month | 0.00 | (0.15) | 10.59 | (9.49) | 38.23 | |
| LPTX | Leap Therapeutics | 0.01 | 9 per month | 6.90 | 0.14 | 25.00 | (9.43) | 65.13 | |
| ASBP | Aspire BioPharma | (0.1) | 8 per month | 0.00 | (0.24) | 19.52 | (23.85) | 66.08 | |
| ATHA | Athira Pharma | (0.54) | 9 per month | 4.10 | 0.05 | 6.70 | (8.06) | 71.83 | |
| CING | Cingulate | 0.24 | 7 per month | 3.86 | 0.22 | 8.45 | (6.75) | 20.08 | |
| ALLR | Allarity Therapeutics | 0.02 | 8 per month | 0.00 | (0.16) | 6.93 | (9.02) | 19.54 |
Entero Therapeutics Additional Predictive Modules
Most predictive techniques to examine Entero price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Entero using various technical indicators. When you analyze Entero charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Entero Therapeutics Predictive Indicators
The successful prediction of Entero Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Entero Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Entero Therapeutics based on analysis of Entero Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Entero Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Entero Therapeutics's related companies.
Pair Trading with Entero Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Entero Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Entero Stock
| 0.6 | TRV | The Travelers Companies | PairCorr |
| 0.55 | CSCO | Cisco Systems Earnings Call This Week | PairCorr |
| 0.49 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.4 | MCD | McDonalds Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Entero Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Entero Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Entero Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Entero Therapeutics to buy it.
The correlation of Entero Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entero Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entero Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Entero Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Entero Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Entero Stock
If you are still planning to invest in Entero Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Entero Therapeutics' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |